Skip to main content
. 2022 Dec 2;16:1483. doi: 10.3332/ecancer.2022.1483

Table 2. Treatment and radiotherapy-related characteristics of patients with and without pain (n = 94).

Pain No pain Total population p-value
n = 59 n = 35
n (%) n (%) n (%)
Treatment intent 0.467
Radical 49 (83.1) 31 (88.6) 80 (85.1)
Palliative 10 (16.9) 4 (11.4) 14 (14.9)
Mean dose (Gy) 28.45 ± 19.27 21.94 ± 18.41 0.111
Radiotherapy alone 0.740
Postoperative 12 (20.3) 9 (25.7) 21 (22.3)
After chemotherapy 5 (8.5) 6 (17.1) 11 (11.7)
Preoperative 0 (0) 1 (2.9) 1 (1.1)
Before chemotherapy 2 (3.4) 1 (2.9) 3 (3.2)
Only 12 (20.3) 7 (20) 19 (20.2)
Concurrent chemoradiation 0.231
Postoperative 5 (8.5) 4 (11.4) 9 (9.6)
After chemotherapy 6 (10.2) 1 (2.9) 7 (7.4)
Preoperative 0 (0) 1 (2.9) 1 (1.1)
Before chemotherapy 0 (0) 0 (0) 0 (0)
Only 17 (28.8) 5 (14.3) 22 (23.4)
Hour of treatment 0.183
6:00–9:00 11 (18.6) 8 (22.9) 19 (20.2)
9:00–12:00 11 (18.6) 8 (22.9) 19 (20.2)
12:00–15:00 9 (15.3) 8 (22.9) 17 (18.1)
15:00–18:00 18 (30.5) 3 (8.6) 21 (22.3)
18:00 and beyond 10 (16.9) 8 (22.9) 18 (19.1)
Objective waiting time 0.911
<2 hours 31 (52.5) 19 (54.3) 50 (53.2)
≥2 hours 28 (47.5) 16 (45.7) 44 (46.8)
Subjective waiting time >0.999
Very long 5 (8.5) 2 (5.7) 7 (7.4)
Long 24 (40.7) 14 (40) 38 (40.4)
Short 29 (49.2) 18 (51.4) 47 (50)
Very short 1 (1.7) 1 (2.9) 2 (2.1)
Treatment period in radiotherapy 0.293
Beginning 8 (13.6) 11 (31.4) 19 (20.2)
First quarter 13 (22) 6 (17.1) 19 (20.2)
Half 15 (25.4) 8 (22.9) 23 (24.5)
Third quarter 13 (22) 7 (20) 20 (21.3)
End 10 (16.9) 3 (8.6) 13 (13.8)
Transportation 0.805
Private 11 (18.6) 7 (20) 18 (19.1)
Public 46 (78) 28 (80) 74 (78.7)
Admitted 2 (3.4) 0 (0) 2 (2.1)
Place of residence (mean kilometre) 16.61 ± 14.48 16.46 ± 9.82 0.957